FactorPad
Build a Better Process

Stock Risk Measures for Neurocrine Biosciences Inc

A quantitative factor review as of September 30, 2021.
  1. Company Info - Description, identity and sector data.
  2. Share Data - Stock earnings and key dates.
  3. Market Risk - Beta, size, liquidity and momentum measures.
  4. Financial Risk - Earnings and dividends.
face pic by Paul Alan Davis, CFA
Updated: October 05, 2021
See how we arrive at an overall risk score of 51 for NBIX below.

/ factorpad.com / stocks / f11mdh.html


An ad-free and cookie-free website.


NBIX Risk Report

Overview

Our quantitative data points are meant to provide a high-level understanding of factors in equity risk models for Neurocrine Biosciences Inc. Portfolio managers use these models to forecast risk, optimize portfolios and review performance.

We show how NBIX stock compares to 2,000+ US-based stocks, and to peers in the Manufacturing sector and Biological Product (except Diagnostic) Manufacturing industry.

Please do not consider this data as investment advice. Data is downloaded from sources we deem reliable, but errors may occur.

Company Info

Business Description

Company logo Neurocrine Biosciences is a neuroscience-focused, biopharmaceutical company dedicated to discovering, developing and delivering life-changing treatments for people with serious, challenging and under-addressed neurological, endocrine and psychiatric disorders. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, Parkinson's disease, endometriosis*, uterine fibroids* and clinical programs in multiple therapeutic areas. For nearly three decades, Neurocrine Biosciences has specialized in targeting and interrupting disease-causing mechanisms involving the interconnected pathways of the nervous and endocrine systems.

Identity

Sector and Industry

Share Data

Shares

Earnings and Dividends

Market Risk Measures

Many of the following risk metrics are standardized and transformed into quantitative factors in institutional-level risk models.

Rankings below represent percentiles from 1 to 100, with 1 being the lowest rating of risk.

Systematic Risk

Stocks with higher beta exhibit higher sensitivity to the ups and downs in the market. (↑↑)

Company Size

Stocks with higher market capitalization often have lower risk. (↑↓)

Trading Liquidity

Higher average daily dollar volume over the past 30 days implies lower liquidity risk. (↑↓)

Price Momentum

Higher price momentum stocks, aka recent winners, equate to lower risk for many investors. (↑↓)

Financial Risk Measures

Style risk factors often include measures of profitability and payout levels.

Earnings Yield

Companies with higher earnings generally provide lower risk. (↑↓)

Dividend Yield

Companies with higher dividend yields, if sustaintable, are perceived to have lower risk. (↑↓)

/ factorpad.com / stocks / f11mdh.html


NBIX stock risk
NEUROCRINE BIOSCIENCES INC stock beta
NBIX risk report
NBIX f11mdh
NBIX risk analysis
NBIX volatility
NEUROCRINE BIOSCIENCES INC credit risk
NBIX liquidity risk
NBIX leverage
NBIX valuation
NBIX systematic risk
NBIX specific risk
NEUROCRINE BIOSCIENCES INC volatility
NBIX analysis
NBIX financial ratio

A newly-updated free resource. Connect and refer a friend today.